Science Explorer Back to mapMap
Discussion
Institution · Q Therapeutics (United States)

Most cited papers from Q Therapeutics (United States)

Q Therapeutics (United States)

What are the most cited papers from Q Therapeutics (United States)?

The most cited paper from Q Therapeutics (United States) is "A Python library for probabilistic analysis of single-cell omics data" (Adam Gayoso et al., 2022), with 858 citations. Next come "VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance" (299) and "Selenoprotein Gene Nomenclature" (285).

Showing 50 of 59 papers. Every paper with more than 10 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Python library for probabilistic analysis of single-cell omics data Adam Gayoso et al. · Nature Biotechnology Feb 2022 858
2 VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance Mohamed A. ElTanbouly et al. · Science Open access 16 Jan 2020 299
3 Selenoprotein Gene Nomenclature Vadim N. Gladyshev et al. · Journal of Biological Chemistry Open access 20 Sep 2016 285
4 Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption Iosif Pediaditakis, Konstantia R. Kodella, Dimitris V. Manatakis et al. · Nature Communications Open access 8 Oct 2021 237
5 Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines George Q. Daley et al. · Stem Cell Reports Open access 12 May 2016 228
6 cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications Behnam Ahmadian Baghbaderani, Xinghui Tian, Boon Hwa Neo et al. · Stem Cell Reports Open access 24 Sep 2015 216
7 The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health Christopher A. Lowry et al. · Current Environmental Health Reports Open access 19 Jul 2016 174
8 Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase Anil K. Padyana, Stefan Größ, Lei Jin et al. · Nature Communications Open access 3 Jan 2019 164
9 KEAP1 loss modulates sensitivity to kinase targeted therapy in lung cancer Elsa Beyer Krall et al. · eLife Open access Feb 2017 162
10 AI is a viable alternative to high throughput screening: a 318-target study The Atomwise AIMS Program et al. · Scientific Reports Open access690 authors 2 Apr 2024 139
11 Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants Dante J. Marciani · Trends in Pharmacological Sciences Review 11 Apr 2018 123
12 Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1G93A Mouse Model of ALS Angelo C. Lepore, John M O'Donnell, Andrew S. Kim et al. · PLoS ONE Open access 5 Oct 2011 119
13 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani, Syama Adhikarla, Renuka Sivapatham et al. · Stem Cell Reviews and Reports Open access 10 Jun 2016 94
14 Transplantation of Human Glial Restricted Progenitors and Derived Astrocytes into a Contusion Model of Spinal Cord Injury Ying Jin, Birgit Neuhuber, Anita Kumari Singh et al. · Journal of Neurotrauma Open access 11 Jan 2011 87
15 Banking on iPSC- Is it Doable and is it Worthwhile Susan Solomon, Fernando Juan Pitossi, Mahendra S. Rao · Stem Cell Reviews and Reports Open access 16 Dec 2014 87
16 AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes Minke A.E. Rab, Brigitte A. van Oirschot, Penelope A. Kosinski et al. · Haematologica Open access 23 Jan 2020 83
17 Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors Yang Gao, Tinghu Zhang, Hideki Terai et al. · Cell chemical biology Open access 21 Dec 2017 80
18 scvi-tools: a library for deep probabilistic analysis of single-cell omics data Adam Gayoso et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 29 Apr 2021 71
19 Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination Piotr Walczak, Angelo Homayoun All, Nidhi Rumpal et al. · Glia Open access 29 Dec 2010 69
20 Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity. Christopher M. Carthy, David James Granville, Huijun Jiang et al. · PubMed Aug 1999 67
21 The USP1 Inhibitor KSQ-4279 Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Tumors Louise Cadzow et al. · Cancer Research Open access 26 Aug 2024 60
22 A retrospective analysis of the Alzheimer's disease vaccine progress – The critical need for new development strategies Dante J. Marciani · Journal of Neurochemistry 19 Mar 2016 48
23 Concise Review: Making and Using Clinically Compliant Pluripotent Stem Cell Lines Melissa K. Carpenter, Mahendra S. Rao · Stem Cells Translational Medicine Open access 26 Feb 2015 48
24 Ophthalmic Uses of a Thiol-Modified Hyaluronan-Based Hydrogel Barbara M. Wirostko, Brenda K. Mann, David L. Williams et al. · Advances in Wound Care Open access 14 Oct 2014 46
25 Alzheimer's disease vaccine development: A new strategy focusing on immune modulation Dante J. Marciani · Journal of Neuroimmunology 9 Aug 2015 46
26 Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin Agatha Lyczek, Antje Arnold, Jiangyang Zhang et al. · Experimental Neurology Open access 3 Feb 2017 43
27 Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens Michael R. Schlabach et al. · Journal of Clinical Investigation Open access 14 Dec 2023 42
28 An mRNA vaccine elicits STING-dependent antitumor immune responses Zhe Chen, Chaoyang Meng, Junhua Mai et al. · Acta Pharmaceutica Sinica B Open access 17 Nov 2022 39
29 Human-Induced Pluripotent Stem Cells Manufactured Using a Current Good Manufacturing Practice-Compliant Process Differentiate Into Clinically Relevant Cells From Three Germ Layers Mehdi Shafa, Fan Yang, Thomas Fellner et al. · Frontiers in Medicine Open access 15 Mar 2018 39
30 Genetic interrogation of replicative senescence uncovers a dual role for USP28 in coordinating the p53 and GATA4 branches of the senescence program Anna E. Mazzucco, Agata Smogorzewska, Chanhee Kang et al. · Genes & Development Open access Oct 2017 37
31 Isolation, Characterization and Preclinical Development of Human Glial-Restricted Progenitor Cells for Treatment of Neurological Disorders Robert W. Sandrock, Will Wheatley, Cynthia Levinthal et al. · Regenerative Medicine May 2010 37
32 New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies Dante J. Marciani · Drug Discovery Today 7 Mar 2014 35
33 Expression profiling of human glial precursors James T. Campanelli, Robert W. Sandrock, Will Wheatley et al. · BMC Developmental Biology Open access 23 Oct 2008 35
34 Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity Simone Punt et al. · Cancer Immunology Immunotherapy Open access 29 Oct 2020 34
35 Promising Results from Alzheimer’s Disease Passive Immunotherapy Support the Development of a Preventive Vaccine Dante J. Marciani · Research Open access 2019 31
36 Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of Oligonucleotides In Vivo Laixin Wang, Ramesh K. Prakash, C.A. Stein et al. · Antisense and Nucleic Acid Drug Development Jun 2003 31
37 Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer Eugene Jon Koay et al. · JCO Precision Oncology Open access 23 Aug 2019 29
38 ICV‐transplanted human glial precursor cells are short‐lived yet exert immunomodulatory effects in mice with EAE Heechul Kim, Piotr Walczak, Naser Muja et al. · Glia Open access 12 Apr 2012 29
39 Metabolism of bioconjugate therapeutics: why, when, and how? Hanlan Liu, Jayaprakasam Bolleddula, Andrew J. Nichols et al. · Drug Metabolism Reviews 2 Jan 2020 28
40 Is fucose the answer to the immunomodulatory paradox of Quillaja saponins? Dante J. Marciani · International Immunopharmacology 25 Oct 2015 28
41 Men in Midwifery: A National Survey Ira Kantrowitz‐Gordon, Simon Adriane Ellis, Ann McFarlane · Journal of Midwifery & Women s Health Sep 2014 28
42 An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking Debajit Dey, Suruchi Singh, Saif Khan et al. · Communications Biology Open access 8 Feb 2022 27
43 Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers Louise Cadzow, J. Brenneman, Richard Sullivan et al. · European Journal of Cancer Oct 2020 26
44 Infigratinib Reduces Fibroblast Growth Factor 23 ( FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia Iris Ruth Hartley, Kelly Lauter Roszko, Xiaobai Li et al. · JBMR Plus Open access 10 Jun 2022 25
45 OX40L-expressing recombinant modified vaccinia virus Ankara induces potent antitumor immunity via reprogramming Tregs Ning Yang, Yi Wang, Shuaitong Liu et al. · The Journal of Experimental Medicine Open access 7 Apr 2023 24
46 Effects of immunomodulators on the response induced by vaccines against autoimmune diseases Dante J. Marciani · Autoimmunity 14 Sep 2017 23
47 Human glial progenitor engraftment and gene expression is independent of the ALS environment Amanda M. Haidet-Phillips, Arpitha Doreswamy, Sarah K. Gross et al. · Experimental Neurology Open access 15 Dec 2014 23
48 Targeting FGFR3 Alterations with Adjuvant Infigratinib in Invasive Urothelial Carcinoma: the Phase III PROOF 302 Trial Sumanta Kumar Pal, Diederik Meindert Somford, Petros D. Grivas et al. · Future Oncology Open access 24 May 2022 22
49 A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs Debajit Dey, Enya Qing, Yanan He et al. · Nature Communications Open access 15 Dec 2023 17
50 Can cord blood banks transform into induced pluripotent stem cell banks? Hongyan Zhou, Mahendra S. Rao · Cytotherapy 12 Mar 2015 17

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.